Back to ESLA

Estrella Immunopharma, Inc. 8-K

Accession 0001213900-25-015364

Filing information

CIK
0001844417
Report date
2025-02-19
Filing date
2025-02-20
Form
8-K
Primary document
ea0231621-8k_estrella.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.